L2Be Pharma
ActiveFrom the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
L2Be Pharma has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €57,221 and a net result of €14,987. Equity remains stable across the filed financial years (±1.2% per year). Its solvency ranks better than 39% of 4,331 sector peers (NACE 74, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
03-10
Gazette deed
Registered officeRegistered-office move · Director in office3 facts ▸
- General meeting, 01-08-2024
- Registered-office move, 7130 Binche - Rue Saint-Paul 47
- Director in office, Leila Boudaka (director)
16-08
Gazette deed
Registered officeRegistered-office move · Director in office · Power of attorney4 facts ▸
- Board meeting, 01-07-2022
- Registered-office move, Rue Provinciale 47 à 7120 Estinnes
- Director in office, Leila BOUDAKA (director)
- Power of attorney
Sources:Publications in the Belgian Official GazetteFilings with the National Bank